Your partner in complex PCI

Complex PCI cases are becoming more common. Leading to an increased risk of adverse events.1


Procedural guidance and vessel preparation tailored to the patient’s needs may help you overcome some of the challenges of complex PCI and achieve better outcomes. 

Philips provides a portfolio of specialty coronary tools that enable safe and effective treatment for a wide variety of complex PCI cases. Explore the different morphologies seen in complex PCI cases and how these tools can help you succeed.

EuroPCR 2022 banner

Purposeful innovation. Empowered care.

Philips at AICT-AsiaPCR 2022
6-8 October,
Singapore
SUNTEC Convention and Exhibition Center


To empower better heart care, Philips uniquely innovates and integrates imaging, devices, software, informatics and services.

We look forward to connecting with you online or at our Symposia and Training Village.

Join our symposium

Clinicians operating Azurion Clarity IQ

EVOLVING APPROACHES TO PLANNING AND GUIDING OF COMPLEX PCI WITH ULTRA-LOW CONTRAST

October 6 | 13:25-14:10 | Orchid Studio

Moderator : DrFahim Jafary
Anchorperson: Jean Fajadet
Speakers: Dr Aaron Wong, Dr Roberta Spina
Discussants:Dr Sidney Lo, Dr Rohan Bhagwandeen
Chat master: Dr Chin Chee Yang

Training village


Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence,  improving cardiac care experiences for staff and patients. Join our training village at AICT-AsiaPCR and learn more. 

Explore Complex PCI morphologies

Let us know how we can help you today.

Educational opportunities and trainings

The logo of Philips Elite Academy
An icon of a doctor speaking with the additional text on the right stating: key thought leaders
The logo of a clipboard with the text; clinical expertise on the right side
a logo of a person getting an idea with the text of product knowledge on the right

Educating leaders in intravascular imaging and therapy excellence


Philips ELIITE Academy is focused on delivering high value and real-time strategic educational programs that meet the evolving needs of our customers.


To initiate your clinical pathway or register for one our cardiovascular US medical educational programs, please contact your local Philips representative.


For more information on the available courses, please download our Medical Education brochure or visit www.philipseliiteacademy.com.

References

1. Witzenbichler B et al. Relationship Between Intravascular Ultrasound Guidance and Clinical Outcomes After Drug-Eluting Stents: The ADAPT-DES Study. Circulation 2014 Jan: 129,4;463-470.
2. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.
3. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet. 2010 Jan 16;375(9710):201-9.
4. Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of restenosis after coronary stenting in 10,004 patients with surveillance angiography. Heart 2014; 100:153–9.
5. Stone, G., et. al. (2005). Percutaneous recanalization of chronically occluded coronary arteries: A consensus document: Part 1. Circulation, 112, 2364- 2372.
6. Généreux P, Madhavan MV, Mintz GS, Maehara A, Palmerini T, Lasalle L, Xu K, McAndrew T, Kirtane A, Lansky AJ, Brener SJ, Mehran R, Stone GW. Ischemic outcomes after coronary intervention of calcified vessels in acute coronary syndromes. Pooled analysis from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) and ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) TRIALS. J Am Coll Cardiol. 2014 May 13;63(18):1845- 54. doi: 10.1016/j.jacc.2014.01.034. Epub 2014 Feb 19. PMID: 24561145.
7. Xu B., Gao R. L., Zhang R. Y., et al. Efficacy and safety of FIREHAWK abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort. Chinese Medical Journal. 2013;126(6):1026–1032.
8. Ahn J. M., Park D. W., Kim Y. H., et al. Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions a randomized LONG-DES IV trial. Circulation: Cardiovascular Interventions. 2012;5(5):633–640.
9. Costa RA, Mooney MR, Teirstein PS, et al. Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions Cardiovascular Revascularization Medicine 7 (2006)81–126.

1
Select your area of interest
2
Contact details

We are always interested in engaging with you.

Let us know how we can help.

1
2
Contact details

You are about to visit a Philips global content page

You are about to visit the Philips USA website.

Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.